The IMDEA Nutrition, one of the seven Madrid Institutes for Advanced Studies (IMDEA), is a public research center founded in 2007 by Madrid’s regional government. The goal of the Institute is to generate science of excellence in the field of food on which to support solutions to social problems and to contribute to a knowledge-based economic model capable of generating high added value.
The mission of the IMDEA Nutrition is to generate scientific knowledge of excellence in the field of food, to improve the quality of life of the population and to contribute to the development of an economic model based on the creation of value from knowledge-based innovation. The Institute’s hallmark is the study of the relationship between genes and nutrients with special emphasis on the prevention and treatment of chronic diseases through precision nutrition. IMDEA Food advances its lines of research through the strategies and tools of nutritional genomics, in fields such as cancer, ageing, obesity and cardiometabolic diseases.
Centers / Institutes
Platform for clinical trials in nutrition and health (GENYAL) & Precision Nutrition and Cancer Group
The Platform for Clinical Trials in Nutrition and Health (GENYAL) constitutes a high-level scientific tool to assess the biological activity and health properties of food, supplements, targeted nutritional strategies and functional foods, taking into account the specific characteristics of population subgroups. Thus, GENYAL is a specialized platform for clinical trials in Precision Nutrition.
GENYAL Platform and Precision Nutrition Cancer Group constitute a multidisciplinary alliance working in coordination and continuous collaboration with the mission of establishing a network of knowledge and work that encompasses a multitasking team to develop precision nutrition strategies. The scope of action goes from the study and identification of molecular and metabolic alterations, and the analysis of in vitro mechanisms of action of the different nutritional strategies and bioactive products targeting these alterations, towards the application of identified personalized nutritional strategies in humans, including clinical trials in both, healthy volunteers and cancer patients.
DiBaN Research Team
Mª Isabel Espinosa Salinas (Principal Investigator)
ORCID: 0000-0002-9526-891X
Ricardo Ramos Ruiz
ORCID: 0000-0002-6331-9786
Marta Gómez de Cedrón
ORCID: 0000-0002-0894-970X
Cristina María Fernández
ORCID: 0000-0003-0539-7636
Silvia Cruz Gil
ORCID: 0000-0003-4012-5548
Susana Molina Arranz
ORCID: 0000-0001-7737-5562
Beatriz Arce López
ORCID: 0000-0001-7690-8777
Guadalupe Ximena Bazán
ORCID: 0009-0002-7085-9016
Platform for clinical trials in nutrition and health (GENYAL) & Precision Nutrition and Cancer Group
The Platform for Clinical Trials in Nutrition and Health (GENYAL) constitutes a high-level scientific tool to assess the biological activity and health properties of food, supplements, targeted nutritional strategies and functional foods, taking into account the specific characteristics of population subgroups. Thus, GENYAL is a specialized platform for clinical trials in Precision Nutrition.
GENYAL Platform and Precision Nutrition Cancer Group constitute a multidisciplinary alliance working in coordination and continuous collaboration with the mission of establishing a network of knowledge and work that encompasses a multitasking team to develop precision nutrition strategies. The scope of action goes from the study and identification of molecular and metabolic alterations, and the analysis of in vitro mechanisms of action of the different nutritional strategies and bioactive products targeting these alterations, towards the application of identified personalized nutritional strategies in humans, including clinical trials in both, healthy volunteers and cancer patients.
DiBaN Research Team
